The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation

被引:32
|
作者
Allen, GA
Monroe, DM
Roberts, HR
Hoffman, M [1 ]
机构
[1] Durham Vet Affairs Med Ctr, Pathol & Lab Med Serv 113, Durham, NC 27705 USA
[2] Univ N Carolina, Ctr Thrombosis & Hemostasis, Chapel Hill, NC USA
[3] Duke Univ, Durham, NC USA
[4] Univ N Carolina, Dept Pediat & Med, Chapel Hill, NC USA
关键词
factor X; factor VIIa; in-vitro model; thrombin; hemophilia;
D O I
10.1097/00001721-200004001-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We used a cell-based, in-vitro model of normal hemostasis and hemophilia to address the question of whether factor (F)X concentration affects the hemostatic response to high-dose activated factor VII(FVIIa). Under conditions designed to mimic normal tissue factor-initiated hemostasis in vivo, we found that only a very small amount of FX - equivalent to about 3% of the normal plasma level - was required to support a 'normal' level of thrombin generation. This suggests that, under normal conditions in vivo, the level of FX does not significantly affect hemostatic function. By contrast, in experiments designed to mimic the hemophilic condition, the level of FX had a significant effect on the level of thrombin generated in the presence of high-dose FVIIa. This finding suggests that the plasma level of FX could affect the hemostatic response of hemophilic patients to high-dose FVIIa therapy. Blood Coagul Fibrinolysis 11 (suppl 1):S3-S7 (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:S3 / S7
页数:5
相关论文
共 50 条
  • [21] Effect of recombinant and plasma-derived von Willebrand Factor on the procoagulant activity of factor VIII in thrombin generation assays
    Knappe, Sabine
    Till, Susanne
    Scheiflinger, Friedrich
    Dockal, Michael
    HAEMOPHILIA, 2014, 20 : 28 - 28
  • [22] Effect of plasminogen activator on the activation of coagulation factor VII
    Tsujioka, H
    Suehiro, A
    Marumo, M
    Higasa, S
    Ueda, M
    Kakishita, E
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1647 - P1647
  • [23] EFFECT OF ANTITHROMBIN-III ON ACTIVITY OF COAGULATION FACTOR-VII, FACTOR-IX AND FACTOR-X
    OSTERUD, B
    MILLERANDERSSON, M
    ABILDGAARD, U
    PRYDZ, H
    THROMBOSIS AND HAEMOSTASIS, 1976, 35 (02) : 295 - 304
  • [24] Effect of varied procoagulant concentration on thrombin generation in a model system
    Allen, GA
    Wolberg, AS
    Oliver, JA
    Hoffman, M
    Roberts, HR
    Monroe, DM
    THROMBOSIS AND HAEMOSTASIS, 1999, : 316 - 317
  • [25] Reversal of dabigatran effects by factor VIIa in a cell-based model of coagulation
    Hoffman, M.
    Volovyk, Z.
    Monroe, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 167 - 168
  • [26] ACTIVATION AND CONTROL OF FACTOR-VII BY ACTIVATED FACTOR-X AND THROMBIN - ISOLATION AND CHARACTERIZATION OF A SINGLE CHAIN FORM OF FACTOR-VII
    RADCLIFFE, R
    NEMERSON, Y
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1975, 250 (02) : 388 - 395
  • [27] A plasma-and cell-based thrombin generation assay to assess the anticoagulant effect of tissue factor pathway inhibitor on endothelial cells
    Gerstenbauer, G.
    Knappe, S.
    Panholzer, E.
    Prohaska, K.
    Knofl, F.
    Ullrich, N.
    Pachlinger, R.
    Scheiflinger, F.
    Dockal, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 562 - 563
  • [28] THE EFFECT OF WARFARIN AND FACTOR-VII ON TISSUE PROCOAGULANT ACTIVITY AND METASTASIS
    FRANCIS, JL
    CARTY, N
    TAYLOR, I
    ROATH, OS
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 874 - 874
  • [30] Use of the thrombin generation test to evaluate response to treatment with recombinant activated factor VII
    Dargaud, Yesim
    Bordet, Jean-Claude
    Lienhart, Anne
    Negrier, Claude
    SEMINARS IN HEMATOLOGY, 2008, 45 (02) : S72 - S73